Tech Transfer eNews Blog

UT Dallas signs option agreement for robotics-based medical technologies

By Jesse Schwartz
Published: April 5th, 2017

Robotics company Bionik Laboratories Corp. has signed an option agreement with the University of Texas (UT) at Dallas to potentially commercialize robotics technologies that address health care needs.

Under the terms of the agreement, Bionik will evaluate the viability of the UT technologies over a one-year period, with the option to negotiate either a non-exclusive or an exclusive, worldwide license under certain patent rights owned by UT Dallas. 

Bionik develops robotics solutions to achieve effective and affordable health care for patients with neurological disorders, with a primary focus on exoskeleton technology. Bionik co-founder and chief technology officer Michal Prywata says the company is “extremely pleased to forge this strategic relationship with the University of Texas at Dallas.”

“Bionik has determined that possessing access to the world’s leading robotics technology is paramount to developing state-of-the-art robotics and establishing ourselves as a leader within the emerging medical device industry,” Prywata adds. “We entered into this option agreement as our preliminary investigation has indicated that this infusion of technology and innovation will provide a strong, competitive advantage to our current technology platform, and that the company can extend its exoskeleton robotic platform and improve our existing technology.”

Robert Gregg, robotics researcher at UT and co-developer of the optioned technology, comments, “We are extremely pleased to work with an innovative company such as Bionik Laboratories so that the results of our research can benefit the most people. These innovations in control systems and novel actuation technologies greatly improve robotic performance and will ultimate produce better mobility for a larger patient population.

“During Bionik’s option period,” Gregg says, “we will work closely with [the company] to advance the technology that will allow them to enhance and commercialize their assistive robotics solution and improve quality of life for persons with these disabilities.”

Source: Nasdaq GlobeNewswire

Posted under: Tech Transfer e-News

Twitter Facebook Linkedin Pinterest Email

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment